Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132440) titled 'Study on the mechanism of metformin regulating macrophage death to improve pre-eclampsia through TLR4/NF-KB/NLRP3 axis' on Sept. 14.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: Zhejiang Xiaoshan Hospital

Condition: Pre-eclampsia,PE

Intervention: Normal pregnant group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Normal pregnant group:15;Preeclampsia pregnant group:15;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=326676

Published by HT Digital Co...